{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:17:36Z","timestamp":1791231456673,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intragastric balloon (IGB) therapy is a minimally invasive endoscopic intervention primarily utilized for weight reduction in patients with Class I and II obesity. While less frequently utilized in individuals with Class III obesity (BMI\u2009\u2265\u200940\u00a0kg\/m\u00b2), IGB placement may be considered as a bridge to bariatric surgery or when surgery is contraindicated or declined. However, data regarding short-term safety outcomes in this higher-risk population remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to compare 30-day safety outcomes after IGB placement in patients with BMI\u2009\u2265\u200940\u00a0kg\/m\u00b2 versus BMI\u2009&lt;\u200940\u00a0kg\/m\u00b2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective cohort study of 4,555 patients undergoing primary IGB placement from 2016 to 2023 using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database. Primary outcomes included hospital length of stay and 30-day rates of outpatient intravenous (IV) treatments, emergency department (ED) visits, readmissions, reoperations, interventions, and mortality. Patients were stratified by BMI\u2009\u2265\u200940\u00a0kg\/m\u00b2 and BMI\u2009&lt;\u200940\u00a0kg\/m\u00b2 for comparative analysis using propensity score-matching (PSM). 962 pairs were identified for PSM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with BMI\u2009\u2265\u200940\u00a0kg\/m\u00b2 were younger on average and more likely to be male and non-Hispanic Black. This group exhibited a higher prevalence of associated medical problems, including diabetes, obstructive sleep apnea, hypertension, renal insufficiency, immunosuppressant use, thromboembolic events, and therapeutic anticoagulation use. After adjustment for baseline differences, patients with BMI\u2009\u2265\u200940\u00a0kg\/m\u00b2 were more likely to require a postoperative hospital length of stay longer than one day (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003). No significant differences in 30-day outpatient IV treatments, ED visits, readmissions, reoperations, interventions, or mortality, were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with BMI\u2009\u2265\u200940\u00a0kg\/m\u00b2 exhibited a greater burden of associated medical problems and longer hospital length of stay, but otherwise demonstrated comparable short-term safety outcomes to those with BMI\u2009&lt;\u200940\u00a0kg\/m\u00b2. These findings suggest comparable 30-day hospital-based safety outcomes after IGB placement in patients with BMI\u2009\u2265\u200940\u00a0kg\/m\u00b2 compared with BMI\u2009&lt;\u200940\u00a0kg\/m\u00b2.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11695-026-08575-8","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T03:17:31Z","timestamp":1773544651000},"page":"1757-1765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety Profile of Primary Intragastric Balloon Placement in Class III Obesity: An MBSAQIP Analysis of 4,555 Patients"],"prefix":"10.1007","volume":"36","author":[{"given":"Sevag","family":"Hamamah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil S.","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizi","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Samakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulmeet K.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barham K.","family":"Abu Dayyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabindra R.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,15]]},"reference":[{"issue":"9","key":"8575_CR1","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.14309\/ajg.0000000000000239","volume":"114","author":"F Bazerbachi","year":"2019","unstructured":"Bazerbachi F, Vargas EJ, Abu Dayyeh BK. Endoscopic bariatric therapy: a guide to the intragastric balloon. Am J Gastroenterol. 2019;114(9):1421\u201331.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"8575_CR2","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1007\/s11695-025-07838-0","volume":"35","author":"M Kermansaravi","year":"2025","unstructured":"Kermansaravi M, Esparham A, Parmar C, Husain FA, Solouki A, Mahjoubi M, et al. Intragastric balloon as a bridge before metabolic and bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2025;35(5):1934\u201346.","journal-title":"Obes Surg"},{"key":"8575_CR3","unstructured":"Crossan K, Sheer AJ. Intragastric balloon. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan, StatPearls Publishing LLC."},{"issue":"3","key":"8575_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/ijo.2016.229","volume":"41","author":"A Courcoulas","year":"2017","unstructured":"Courcoulas A, Abu Dayyeh BK, Eaton L, Robinson J, Woodman G, Fusco M, et al. Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial. Int J Obes (Lond). 2017;41(3):427\u201333.","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"8575_CR5","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.soard.2014.12.006","volume":"11","author":"J Ponce","year":"2015","unstructured":"Ponce J, Woodman G, Swain J, Wilson E, English W, Ikramuddin S, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015;11(4):874\u201381.","journal-title":"Surg Obes Relat Dis"},{"issue":"2","key":"8575_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11695-021-05772-5","volume":"32","author":"JH Loo","year":"2022","unstructured":"Loo JH, Lim YH, Seah HL, Chong AZQ, Tay KV. Intragastric balloon as bridging therapy prior to bariatric surgery for patients with severe obesity (BMI\u2009\u2265\u200950 kg\/m(2)): a systematic review and meta-analysis. Obes Surg. 2022;32(2):489\u2013502.","journal-title":"Obes Surg"},{"issue":"7","key":"8575_CR7","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.4240\/wjgs.v16.i7.2040","volume":"16","author":"D Abbitt","year":"2024","unstructured":"Abbitt D, Choy K, Kovar A, Jones TS, Wikiel KJ, Jones EL. Weight regain after intragastric balloon for pre-surgical weight loss. World J Gastrointest Surg. 2024;16(7):2040\u20136.","journal-title":"World J Gastrointest Surg"},{"issue":"5","key":"8575_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000485428","volume":"25","author":"J Ribeiro da Silva","year":"2018","unstructured":"Ribeiro da Silva J, Proen\u00e7a L, Rodrigues A, Pinho R, Ponte A, Rodrigues J, et al. Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy. GE Port J Gastroenterol. 2018;25(5):236\u201342.","journal-title":"GE Port J Gastroenterol"},{"issue":"1","key":"8575_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ags3.12049","volume":"2","author":"M Ri","year":"2018","unstructured":"Ri M, Aikou S, Seto Y. Obesity as a surgical risk factor. Ann Gastroenterol Surg. 2018;2(1):13\u201321.","journal-title":"Ann Gastroenterol Surg"},{"issue":"2","key":"8575_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/bja\/aep374","volume":"104","author":"RE McKay","year":"2010","unstructured":"McKay RE, Malhotra A, Cakmakkaya OS, Hall KT, McKay WR, Apfel CC. Effect of increased body mass index and anaesthetic duration on recovery of protective airway reflexes after sevoflurane vs desflurane. Br J Anaesth. 2010;104(2):175\u201382.","journal-title":"Br J Anaesth"},{"key":"8575_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164635","author":"L Sundararaman","year":"2024","unstructured":"Sundararaman L, Goudra B. Sedation for GI endoscopy in the morbidly obese: challenges and possible solutions. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13164635.","journal-title":"J Clin Med"},{"key":"8575_CR12","doi-asserted-by":"crossref","unstructured":"Sahin TT, Kutluturk K. Preoperative evaluation of the morbidly obese patients for bariatric surgery. Ann Laparosc Endosc Surg. 2020;6.","DOI":"10.21037\/ales-20-49"},{"issue":"6","key":"8575_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1055\/a-2292-2494","volume":"56","author":"P Jirapinyo","year":"2024","unstructured":"Jirapinyo P, Hadefi A, Thompson CC, Patai \u00c1V, Pannala R, Goelder SK, et al. American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity. Endoscopy. 2024;56(6):437\u201356.","journal-title":"Endoscopy"},{"issue":"9","key":"8575_CR14","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1007\/s11695-016-2307-9","volume":"26","author":"E Yorke","year":"2016","unstructured":"Yorke E, Switzer NJ, Reso A, Shi X, de Gara C, Birch D, et al. Intragastric balloon for management of severe obesity: a systematic review. Obes Surg. 2016;26(9):2248\u201354.","journal-title":"Obes Surg"},{"issue":"7","key":"8575_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11695-007-9331-8","volume":"18","author":"I Imaz","year":"2008","unstructured":"Imaz I, Mart\u00ednez-Cervell C, Garc\u00eda-Alvarez EE, Sendra-Guti\u00e9rrez JM, Gonz\u00e1lez-Enr\u00edquez J. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18(7):841\u20136.","journal-title":"Obes Surg"},{"issue":"2","key":"8575_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/00365521.2021.1994641","volume":"57","author":"CJ T\u00f8nnesen","year":"2022","unstructured":"T\u00f8nnesen CJ, Hjelmes\u00e6th J, Hofs\u00f8 D, Tonstad S, Hertel JK, Heggen E, et al. A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trial. Scand J Gastroenterol. 2022;57(2):232\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"8575_CR17","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1007\/s11695-020-04798-5","volume":"30","author":"RL Moore","year":"2020","unstructured":"Moore RL, Eaton L, Ellner J. Safety and effectiveness of an intragastric balloon as an adjunct to weight reduction in a post-marketing clinical setting. Obes Surg. 2020;30(11):4267\u201374.","journal-title":"Obes Surg"},{"issue":"11","key":"8575_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.soard.2018.07.010","volume":"14","author":"H Ashrafian","year":"2018","unstructured":"Ashrafian H, Monnich M, Braby TS, Smellie J, Bonanomi G, Efthimiou E. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series. Surg Obes Relat Dis. 2018;14(11):1691\u20139.","journal-title":"Surg Obes Relat Dis"},{"issue":"9","key":"8575_CR19","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1007\/s11695-024-07418-8","volume":"34","author":"AC Pinho","year":"2024","unstructured":"Pinho AC, Manco AL, Silva M, Sousa HS, Resende F, Preto J, et al. Intragastric balloon as a first step before metabolic bariatric surgery in patients with BMI\u2009\u2265\u200950 kg\/m(2): are the results after balloon related to global outcomes after surgery? Obes Surg. 2024;34(9):3195\u2013202.","journal-title":"Obes Surg"},{"issue":"1","key":"8575_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.ijo.0803094","volume":"30","author":"A Genco","year":"2006","unstructured":"Genco A, Cipriano M, Bacci V, Cuzzolaro M, Materia A, Raparelli L, et al. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond). 2006;30(1):129\u201333.","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"8575_CR21","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1007\/s11695-019-03794-8","volume":"29","author":"W Ball","year":"2019","unstructured":"Ball W, Raza SS, Loy J, Riera M, Pattar J, Adjepong S, et al. Effectiveness of intra-gastric balloon as a bridge to definitive surgery in the super obese. Obes Surg. 2019;29(6):1932\u20136.","journal-title":"Obes Surg"},{"issue":"2","key":"8575_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/sjg.sjg_272_24","volume":"31","author":"MS Khan","year":"2025","unstructured":"Khan MS, Alzanbagi A, Tashkhandi A, Qurashi LA, ElBahrawy A, Khogeer A, et al. A single-center experience of safety and effectiveness of adjustable intragastric balloon in patients with super obesity. Saudi J Gastroenterol. 2025;31(2):93\u20139.","journal-title":"Saudi J Gastroenterol"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08575-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08575-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08575-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:08:25Z","timestamp":1781640505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-026-08575-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["8575"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08575-8","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study utilized de-identified data from the MBSAQIP database. All data were collected and provided in a manner that protects patient confidentiality, and no identifiable personal health information was accessed or used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical\/board approval"}},{"value":"GPT-5 was used to assist with language editing during the preparation of this abstract. The authors reviewed and approved the final content.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial intelligence disclosure"}},{"value":"Disclosures: Dr. Kulmeet K. Sandhu is a consultant for Johnson and Johnson. Dr. Kenneth Park is a consultant for Boston Scientific, Cook Medical, MicroTech, Olympus, and EndoRobotics. Dr. Barham K. Abu Dayyeh serves as a consultant for Boston Scientific and Olympus. He has received research support for the conduct of the MERIT trial from Apollo Endosurgery, now Boston Scientific; this support was provided to his previous institution (Mayo Clinic), and he did not receive personal compensation related to the trial. Dr. Barham K. Abu Dayyeh is also a co-inventor of the Endogenex technology, which has been licensed by the Mayo Clinic to Endogenex. Dr. Rabindra R. Watson is a consultant, speaker and receives research support from Boston Scientific. All other authors have no relevant conflicts of interest or financial disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}